| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.32B | 2.31B | 2.07B | 1.79B | 1.44B | 1.35B |
| Gross Profit | 568.79M | 579.89M | 501.74M | 424.81M | 269.64M | 363.49M |
| EBITDA | 225.56M | 247.66M | 211.83M | 159.46M | -25.84M | 164.03M |
| Net Income | 140.87M | 143.23M | 104.18M | 75.51M | -93.53M | 79.05M |
Balance Sheet | ||||||
| Total Assets | 1.90B | 2.00B | 1.97B | 1.75B | 1.74B | 1.80B |
| Cash, Cash Equivalents and Short-Term Investments | 431.94M | 339.44M | 376.79M | 307.08M | 252.68M | 393.94M |
| Total Debt | 43.57M | 46.06M | 74.77M | 137.24M | 164.59M | 148.65M |
| Total Liabilities | 622.48M | 732.00M | 772.01M | 617.98M | 644.28M | 611.10M |
| Stockholders Equity | 1.34B | 1.32B | 1.25B | 1.18B | 1.14B | 1.23B |
Cash Flow | ||||||
| Free Cash Flow | 202.30M | 35.34M | 168.03M | 104.74M | -143.42M | 9.09M |
| Operating Cash Flow | 254.43M | 113.13M | 228.66M | 129.75M | -98.65M | 100.12M |
| Investing Cash Flow | -50.99M | -69.52M | -53.28M | -23.64M | -38.79M | -89.62M |
| Financing Cash Flow | -97.63M | -86.45M | -103.41M | -45.39M | -8.03M | 19.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$670.53M | 4.73 | 10.86% | 10.87% | 6.86% | 18.44% | |
74 Outperform | HK$429.34M | 4.39 | 17.17% | 8.49% | 21.99% | 11.36% | |
73 Outperform | HK$307.70M | 2.56 | 19.34% | ― | -3.12% | 1.92% | |
70 Outperform | HK$290.23M | 12.34 | 5.51% | 6.61% | -34.28% | -45.72% | |
66 Neutral | HK$363.93M | 6.31 | 10.92% | ― | 11.10% | -4.38% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$295.66M | 9.85 | 3.77% | 10.32% | -6.67% | -29.55% |
Ming Fai International Holdings Limited reported a decrease in revenue and gross profit for the nine months ending September 2025, attributed mainly to the relocation of production facilities from China to Cambodia due to U.S. tariff policies. This shift impacted the health care and hygienic products business, although the operating supplies and equipment business saw an increase in revenue. The company’s gross profit margin also declined due to rising manufacturing costs. Despite these challenges, the company maintains a strong cash position and is actively exploring new business opportunities while monitoring global economic risks.